CLOVER (CLOstridium difficile Vaccine Efficacy Trial) study: A phase 3, randomized trial investigating the efficacy and safety of a detoxified toxin A/B vaccine in adults 50 years and older at increased risk of Clostridioides difficile infection

Authors

Curtis J Donskey, Louis Stokes Cleveland Veterans Affairs Medical Center
Erik R Dubberke, Washington University School of Medicine in St. Louis
et al.

Journal

Clinical infectious diseases

Publication Date

12-17-2024

Volume

79

Issue

6

First Page

1503

Last Page

1511

Document Type

Open Access Publication

DOI

10.1093/cid/ciae410

Rights and Permissions

Curtis J Donskey, Erik R Dubberke, Nicola P Klein, Elizabeth G Liles, Katarzyna Szymkowiak, Mark H Wilcox, Jody Lawrence, Salim Bouguermouh, Haiying Zhang, Kenneth Koury, Ruth Bailey, Helen M Smith, Stephen Lockhart, Erik Lamberth, Warren V Kalina, Michael W Pride, Chris Webber, Annaliesa S Anderson, Kathrin U Jansen, William C Gruber, Nicholas Kitchin, on behalf of the CLOVER (CLOstridium difficile Vaccine Efficacy tRial) Study Group, CLOVER (CLOstridium difficile Vaccine Efficacy tRial) Study: A Phase 3, Randomized Trial Investigating the Efficacy and Safety of a Detoxified Toxin A/B Vaccine in Adults 50 Years and Older at Increased Risk of Clostridioides difficile Infection, Clinical Infectious Diseases, Volume 79, Issue 6, 15 December 2024, Pages 1503–1511, https://doi.org/10.1093/cid/ciae410. https://academic.oup.com/cid/article/79/6/1503/7740506?login=true. © The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Donskey, Curtis J; Dubberke, Erik R; and et al., "CLOVER (CLOstridium difficile Vaccine Efficacy Trial) study: A phase 3, randomized trial investigating the efficacy and safety of a detoxified toxin A/B vaccine in adults 50 years and older at increased risk of Clostridioides difficile infection." Clinical infectious diseases. 79, 6. 1503 - 1511. (2024).
https://digitalcommons.wustl.edu/oa_4/4787

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.